Oxeia to Enroll Patients in Concussion Symptom Therapy Clinical Trial
Oxeia Biopharmaceuticals plans to enroll 160 patients in a Phase 2b clinical trial of OXE103, therapy for persistent concussion symptoms.
Oxeia Biopharmaceuticals plans to enroll 160 patients in a Phase 2b clinical trial of OXE103, therapy for persistent concussion symptoms.
CurePSP awarded CARES grants for multi-center projects aimed at improving care, access, and education for patients with PSP, CBD, and MSA.
Researchers evaluated how efficiently the hip-assist robot improved the mobility, dynamic balance, and range of movement in the elderly.
Researchers found that a Mediterranean-based ketogenic diet may decrease the risk factors of Alzheimer’s disease.
Read MoreThe medical study showed how a certain type of immersive audio improves virtual reality for users, improving efficacy for rehab.
Read MoreAn exaggerated anti-inflammatory response is likely responsible for Long COVID Syndrome (LCS), researchers suggest.
Read MoreVitamin D supplementation reduces the risk of dynapenia in older people by 78%, researchers suggest in a new study.
Read MoreRehabilitation to address distorted body perception in stroke survivors may improve outcomes, according to researchers in a new study.
Read MoreExercise can change not just waistlines but the very molecules in the human body that influence how genes behave, a study of twins suggests.
Read MoreA study suggests ways for making cartilage cells with implications in regenerative medicine for cartilage injuries & degeneration treatments.
Read MoreTechnology that can change skin tissue into blood vessels and nerve cells has also shown promise as a treatment for traumatic muscle loss.
Read MoreAn NIH-funded clinical trial investigating ESStim, a brain stimulation technology to treat carpal tunnel syndrome, has advanced to Phase II.
Read MoreUsing Osteoboost more than three times per week reduced the loss of vertebral bone strength and had no adverse effects, per a pivotal trial.
Read MoreBRAINBox Solutions has enrolled the 1,000th patient in the HeadSMART II study of its concussion diagnostic and prognostic test, BRAINBox TBI.
Read MoreA second generation Integrated Motion Analysis Suite is being used as part of an NIH-funded trial investigating ESStim for Parkinson’s.
Read MoreZimmer Biomet Holdings Inc announces one-year data from a trial to evaluate the impact of mymobility with Apple Watch.
Read MoreEsya Labs will be partnering with MSD to validate peripheral biomarkers for Parkinson’s disease and accelerate therapeutics development.
Read MoreResults of a study surrounding the effects of physical therapy when combatting musculoskeletal complaints were revealed recently.
Read More